Literature DB >> 22199267

Characterization of T-cell memory phenotype after in vitro expansion of tumor-infiltrating lymphocytes from melanoma patients.

Juhua Zhou1, Prakash Nagarkatti, Yin Zhong, Mitzi Nagarkatti.   

Abstract

Memory T-cell populations in human antitumor tumor-infiltrating lymphocytes (TILs) for adoptive cell transfer have not been fully characterized. Our studies demonstrated that CD62L, CD27 and CD28 positive effector memory T-cells were present in the TIL samples from the tumor tissues of melanoma patients and T-cell expansion led to the significant loss of memory T-cells. CD27- and CD28-positive T-cells had high levels of CD44 expression. T-Cell expansion resulted in significant down-regulation of CD44 expression. Interleukin-2 (IL-2) and anti-CD3 antibody stimulation may be responsible for CD44 down-regulation on CD8(+) T-cells during expansion. Furthermore, CD44 down-regulation using small interfering RNA (siRNA) on TILs dramatically reduced interferon-gamma and IL-2 release upon tumor stimulation. These results suggest that the regulation of CD44 expression in TILs may play an important role in memory T-cell maintenance and antitumor immune response.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22199267      PMCID: PMC4796947     

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  49 in total

1.  CD44 supports T cell proliferation and apoptosis by apposition of protein kinases.

Authors:  N Föger; R Marhaba; M Zöller
Journal:  Eur J Immunol       Date:  2000-10       Impact factor: 5.532

2.  In vitro stimulation and expansion of human tumour-reactive CD8+ cytotoxic T lymphocytes by anti-CD3/CD28/CD137 magnetic beads.

Authors:  D Teschner; G Wenzel; E Distler; E Schnürer; M Theobald; A A Neurauter; K Schjetne; W Herr
Journal:  Scand J Immunol       Date:  2011-08       Impact factor: 3.487

3.  Telomere length of transferred lymphocytes correlates with in vivo persistence and tumor regression in melanoma patients receiving cell transfer therapy.

Authors:  Juhua Zhou; Xinglei Shen; Jianping Huang; Richard J Hodes; Steven A Rosenberg; Paul F Robbins
Journal:  J Immunol       Date:  2005-11-15       Impact factor: 5.422

4.  A role for CD44 in T cell development and function during direct competition between CD44+ and CD44- cells.

Authors:  Victoria A Graham; Amanda L Marzo; David F Tough
Journal:  Eur J Immunol       Date:  2007-04       Impact factor: 5.532

5.  Persistence of multiple tumor-specific T-cell clones is associated with complete tumor regression in a melanoma patient receiving adoptive cell transfer therapy.

Authors:  Juhua Zhou; Mark E Dudley; Steven A Rosenberg; Paul F Robbins
Journal:  J Immunother       Date:  2005 Jan-Feb       Impact factor: 4.456

6.  Blockade of CD27/CD70 pathway to reduce the generation of memory T cells and markedly prolong the survival of heart allografts in presensitized mice.

Authors:  Helong Dai; Jibing Chen; Wei Shao; Feng Wang; Shuo Xu; Yuanzheng Peng; Yingying Lin; Junjie Xia; Henrik Ekberg; Xiaomin Wang; Zhongquan Qi
Journal:  Transpl Immunol       Date:  2011-03-22       Impact factor: 1.708

Review 7.  Longevity of T-cell memory following acute viral infection.

Authors:  Joshua M Walker; Mark K Slifka
Journal:  Adv Exp Med Biol       Date:  2010       Impact factor: 2.622

Review 8.  Role of CD44 in CTL and NK cell activity.

Authors:  A Q Rafi-Janajreh; P S Nagarkatti; M Nagarkatti
Journal:  Front Biosci       Date:  1998-07-01

9.  Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections.

Authors:  Victor Appay; P Rod Dunbar; Margaret Callan; Paul Klenerman; Geraldine M A Gillespie; Laura Papagno; Graham S Ogg; Abigail King; Franziska Lechner; Celsa A Spina; Susan Little; Diane V Havlir; Douglas D Richman; Norbert Gruener; Gerd Pape; Anele Waters; Philippa Easterbrook; Mariolina Salio; Vincenzo Cerundolo; Andrew J McMichael; Sarah L Rowland-Jones
Journal:  Nat Med       Date:  2002-04       Impact factor: 53.440

10.  Adoptive cell therapy for patients with melanoma.

Authors:  Mark E Dudley
Journal:  J Cancer       Date:  2011-06-15       Impact factor: 4.207

View more
  4 in total

Review 1.  Elements of cancer immunity and the cancer-immune set point.

Authors:  Daniel S Chen; Ira Mellman
Journal:  Nature       Date:  2017-01-18       Impact factor: 49.962

2.  Memory T cells are uniquely resistant to melanoma-induced suppression.

Authors:  Lucy Wentworth; Justin V Meyers; Sheeba Alam; Andrew J Russ; M Suresh; Clifford S Cho
Journal:  Cancer Immunol Immunother       Date:  2012-08-04       Impact factor: 6.968

Review 3.  Can Immunogenic Chemotherapies Relieve Cancer Cell Resistance to Immune Checkpoint Inhibitors?

Authors:  Thaiz Rivera Vargas; Lionel Apetoh
Journal:  Front Immunol       Date:  2019-05-29       Impact factor: 7.561

4.  Transcriptome profiling of human thymic CD4+ and CD8+ T cells compared to primary peripheral T cells.

Authors:  Hanna Helgeland; Ingvild Gabrielsen; Helle Akselsen; Arvind Y M Sundaram; Siri Tennebø Flåm; Benedicte Alexandra Lie
Journal:  BMC Genomics       Date:  2020-05-11       Impact factor: 3.969

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.